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Abstract 
Objective: To determine the feasibility of Specialised Screening Practitioners (SSPs) 
offering patient navigation (PN) to facilitate uptake of bowel scope screening (BSS) among 
patients who do not confirm or attend their appointment. 
Design: A single-stage phase II trial. 
Setting: South Tyneside District Hospital, Tyne and Wear, England, United Kingdom. 
Participants: Individuals invited for BSS at South Tyneside District Hospital during the 6-
month recruitment period were invited to participate in the study.  
Intervention: Consenting individuals were randomly assigned to either the PN intervention 
or usual care group in a 4:1 ratio. The intervention involved BSS non-attenders receiving a 
phone call from a SSP to elicit their reasons for non-attendance, and offer educational, 
practical and emotional support as required. If requested by the patient, another BSS 
appointment was then scheduled. 
Primary outcome measure: The number of non-attenders in the intervention group who 
were navigated and then re-booked and attended their new BSS appointment. 
Secondary outcome measures: Barriers to BSS attendance, patient-reported outcomes 
including informed choice and satisfaction with BSS and the PN intervention, reasons for 
study non-participation, SSPs’ evaluation of the PN process and a cost analysis. 
Results: Of those invited to take part (n = 1050), 152 (14.5%) were randomised into the 
study: PN intervention = 109; Usual care = 43. Most participants attended their BSS 
appointment (PN: 79.8%; Control: 79.1%) leaving 22 eligible for PN: only two were 
successfully contacted. SSPs were confident in delivering PN, but were concerned that low 
BSS awareness and information overload may have deterred patients from taking part in the 
study. Difficulty contacting patients was reported as a burden to their workload.  
Conclusions: PN, as implemented, was not a feasible intervention to increase BSS uptake 
in South Tyneside. Interventions to increase BSS awareness may be better suited to this 
population.  
Trial registration: ISRCTN13314752 
Key words: Feasibility, bowel scope, screening, colorectal cancer, patient navigation 
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Article Summary 
Strengths and limitations of this study 
 Strength: This study was the first to consider patient navigation as an intervention to 
increase uptake of bowel scope screening as part of the UK NHS bowel cancer 
screening programme  
 Strength: We aimed to utilise the already advanced knowledge and communication 
skills of Specialist Screening Practitioners for the delivery of the intervention. 
 Limitation: Contact information obtained by the bowel cancer screening programme 
for people to be invited for BSS does not include telephone numbers and, therefore, 
an opt-in consent process was a necessary design feature for this study. 
 
Introduction 
Colorectal cancer (CRC) is the second most common cause of cancer death in the UK.[1]In 
2013, the NHS Bowel Cancer Screening Programme (BCSP) introduced bowel scope 
screening (BSS) for men and women aged 55 years. BSS involves a once-only flexible 
sigmoidoscopy (FS), a test that can substantially reduce CRC incidence and mortality by 
finding and removing pre-cancerous polyps. However, the benefits of BSS are dependent on 
uptake, which is currently less than optimal at 43.1%, a figure that falls further when the 
focus is on the more deprived areas of England.[2] There is, therefore, a need for 
interventions to increase BSS uptake, and reduce the observed social gradient.  
Patient navigation (PN) is an intervention that aims to remove logistical or psychological 
barriers to healthcare.. It involves the provision of one-to-one tailored support from trained 
individuals (i.e. Patient Navigators) to patients who need it. This may be delivered face-to-
face or via telephone. The concept of PN was originally developed in the US, in 1990, by 
Harold Freeman, in the context of breast cancer screening for patients of low socioeconomic 
status.[3] However, it has since been applied to other cancer types and chronic diseases 
across the healthcare continuum, from prevention to end of life.[4]  
There is a lot of US evidence that PN can increase colorectal cancer screening uptake. A 
randomised controlled trial showed significantly higher rates of screening (completion of 
either a Faecal Occult Blood Test (FOBT) or colonoscopy) among patients in a PN 
intervention group (35%), compared to those in a control group (20%).[5] More recently, 
DeGroff et al. (2017) found that low-income patients who received a PN intervention were 
one and a half times more likely to attend colonoscopy than control participants receiving 
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usual care.[6] Similarly, Rice et al. (2017) found patients assigned to a PN intervention 
condition were 11.2 times more likely to attend colonoscopy than those in the control 
condition.[7] Patients in the navigation intervention group were also significantly more likely 
to have adequate bowel preparation and significantly less likely to miss or cancel their 
appointments.[7] Although PN has not yet been applied to BSS in the UK, it has successfully 
been used to increase uptake of breast screening among African-Caribbean women in two 
socially diverse areas of London.[8] Moreover, a further single site study in London explored 
whether a telephone call from a General Practitioner or Healthcare Assistant to patients who 
had failed to respond to their NHS BCSP invitation to complete a FOBT could help increase 
screening uptake.[9] The call aimed to identify reasons for their non-response and 
encourage participation. The results indicated that the call was successful, with 66% of those 
contacted agreeing to be screened and 50% then completing the test.[9] This suggests that 
a PN telephone intervention could be an effective method to promote BSS attendance in the 
UK. 
The main aim of this study was to determine the feasibility of employing Specialist Screening 
Practitioners (SSPs), who are based within screening centres and whose day to day role is 
to support patients through the screening process, to additionally offer PN to patients who do 
not confirm or attend their BSS appointment. The advantage of delivering PN through 
screening centres as opposed to primary care was the already available infrastructure to 
support patients through their screening journey; for example, readily available expertise and 
knowledge regarding BSS and the BCSP, skills communicating with the public about cancer 
and screening tests, and the ability to directly co-ordinate amendments to screening 
invitations e.g. re-scheduling appointments, arranging for the enema to be administered at 
the hospital. The main potential barrier to delivering PN in this way was that screening 
centres do not have access to the telephone numbers of screening invitees. The objectives 
of this study were, therefore, to determine the feasibility of screening centre delivered PN by 
assessing study recruitment rates (specifically the proportion of screening invitees willing to 
consent to taking part and sharing their contact details); BSS uptake rates of those 
navigated; patients’ satisfaction with PN; SSPs’ satisfaction with PN and the cost of 
delivering the PN intervention.  
 
Method 
Design 
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We used a single-stage phase II trial to determine whether PN could positively impact the 
BSS attendance rate in South Tyneside to a degree that would merit further investigation. 
The protocol for this research has previously been published and should be consulted for 
additional methodological detail.[10] Ethical approval was obtained from NRES Committee 
London-Bloomsbury (letter dated 31st December 2014; REC reference: 14/LO/2308). 
Recruitment and setting 
All individuals invited for BSS at South Tyneside District Hospital (STDH; one of three sites 
operating under the South of Tyne Screening Centre) during the recruitment period (May to 
October 2015) were invited to take part in this study. The South of Tyne Screening Centre 
was chosen because it has below average uptake of BSS, with 37% of invited adults 
attending screening.[2] 
Procedure 
A study invitation was sent with the standard BSS pre-invitation letter, and included a 
participant information sheet (PIS) and consent form to be completed and returned by those 
who wished to participate in the study. The PIS detailed information about the aim of the 
study, consent process, data protection and study procedure, including the telephone 
number that would appear on their screen if they were to receive a PN phone call. It also 
stated that deciding to take part in the study was not the same as deciding to take part in 
screening. The consent form asked individuals to indicate their gender, contact number, 
name and address. Individuals who did not want to participate were asked to complete and 
return an anonymised non-participation postcard (A5 size), using the presented tick box 
options and free text space to indicate their reason(s) for non-participation (Supplementary 
file A).   
The Research Nurse allocated (unblinded) consenting individuals to either the PN 
intervention or control group using a pre-generated, gender specific randomisation list 
(provided by medical statistician). An initial randomisation ratio of 2:1 in favour of the 
intervention was soon increased to 4:1 due to a low response rate. 
As per usual care, two weeks after receiving the pre-invitation letter, consenting participants 
received a BSS appointment date and time (six weeks in advance). This letter requested 
confirmation of their intention to attend the appointment (return of slip or call to centre). If no 
confirmation was received within two weeks, the bowel cancer screening hub sent a 
reminder letter. If confirmation was not received within a further two weeks a cancellation 
letter was then sent. For those in the control group, there was no further contact from the 
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screening centre. If the appointment was confirmed, an enema with instructions was mailed 
out approximately two weeks before the appointment. Patients who confirmed but then failed 
to attend received a ‘DNA’ letter. For those in the control group, again no further contact was 
made. 
For those in the PN group, the PN intervention began following the mail out of the 
cancellation or ‘DNA’ letter. In addition to the original protocol, the PN intervention was also 
initiated following a call made by a patient to the screening centre to cancel their BSS 
appointment without an intention to rebook at a later date. For those who phoned to cancel 
an appointment with a plan to call back and rebook, the PN intervention was only initiated if 
no new appointment was made within 6-8 weeks . As per study protocol, the PN intervention 
involved an SSP trained in how to deliver PN, telephoning the individual to elicit reasons for 
non-attendance, to provide emotional and instrumental support to overcome any barriers 
identified (e.g. assistance with the enema), and, if relevant, to help arrange a new 
appointment.[10]   Good practice required the participant to confirm their agreement to the 
call being recorded at the start of the PN call. 
All participants were sent one of four versions of an End of Study Questionnaire (ESQ) 
approximately 4 weeks after attendance at their BSS appointment, or 1 week after non-
attendance or an unsuccessful PN call (i.e. no response or no new appointment agreed). 
Questions varied across versions depending on relevance to study group and attendance 
status but generally included questions pertaining to demographic details, BSS knowledge 
and decision experience and satisfaction. For those who attended, additional questions 
included the test experience and views on the support they received. Specifically, patient-
reported pain and embarrassment were explored as these are common barriers to screening 
uptake.[11-16]. The ESQ for patients who received PN also aimed to explore the cognitive 
and emotional response to the intervention and its effect on informed choice and BSS 
knowledge. If ESQs were not returned within 2 weeks, a second ESQ was sent as a 
reminder.  
SSP interviews 
The six SSPs (all female) trained to deliver PN were interviewed at the end of the study to 
elicit their perspectives on the delivery of the intervention, including barriers and facilitators, 
and how PN would likely affect their workload if implemented. Semi-structured telephone 
interviews were carried out by the patient representative (LB) involved in the study and 
recorded. Following transcription, the interviews were then analysed for recurrent themes 
using a thematic analysis. 
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Patient involvement 
The research question was developed as part of a stakeholder meeting which included three 
patient representatives. The meeting introduced the PN concept, reviewed previous 
evidence supporting its use and determined the suitability of this strategy in the English 
context. The meeting also determined the appropriateness of using a feasibility study, the 
specific way in which PN should be delivered (e.g. by SSPs) and the potential PPI 
contribution going forward. One of our attending patient representatives became a co-
investigator and was involved in reviewing drafts of the protocol, recruitment materials, the 
lay summary, conference abstracts and reports. In addition, our patient representative (LB) 
went on to help develop the SSP interview schedule, then conducted the interviews, co-
analysed the transcripts and disseminated the results at a conference.   
Cost analysis 
We undertook a detailed bottom-up microcosting exercise to calculate the average cost per 
participant of PN and usual care. Costs mainly comprised staff time and stationary (stamps, 
envelopes, paper, postage and printing charges) associated with the following activities: (1) 
the pre-invitation letter introducing BSS; (2) the invitation letter to participate in BSS with an 
appointment date; (3) the remainder letter that was sent if no confirmation was received from 
the patient; (4) the cancellation letter sent to participants if there is no reply to the reminder 
letter; and, (5) instructions on how to participate in the BSS sent to participants if a 
confirmation letter was received. In additon, for PN we also included the cost of PN training 
and the cost of PN contacts in the event that patients did not respond to the invitation or did 
not attend a confirmed appointment. Unit costs were taken from market prices. 
 
Results 
Response rate 
The response rate was 14.6% (153 out of 1050), which was significantly below the target of 
40%.[10] One consent form was received after the individual had attended their scheduled 
BSS appointment and was therefore excluded from randomisation, resulting in 43 
participants randomly allocated to the control group (female = 23; 53.5%) and 109 to the 
intervention (PN) group (female = 58; 53.2%). The non randomised individual (female) was 
included in the evaluation and sent an ESQ. 
Study decliners 
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Non-participation postcards were returned by 16 people (1.8% of 897 non-consenting 
invitees). The most commonly reported reasons for non-participation were ‘I have already 
decided not to have the BSS test’ (43.8%; n=7), and ‘I do not want to receive additional 
phone calls from the screening centre’ (37.5%; n=6). Other reasons for not having the test 
mostly focused on people currently feeling well/content with life and not wanting to alter this 
by getting involved in screening. 
BSS participation by study group 
The majority of participants attended their original BSS appointment: control = 79.1% and 
PN = 79.8%. This level of attendance was much higher than the 35% average for STDH 
over the study period.[Personal communication; Ritchie, 2016] As a result, only 22 people 
were eligible for the intervention: 12 failed to confirm their appointment, four failed to attend 
a confirmed appointment, and six cancelled their appointment. However, SSPs only called 
19 participants as three were lost to follow up (i.e. erroneously not highlighted as needing 
PN intervention) and only two received PN. The PN received was of a relatively ‘low level’: 
one PN call was audio recorded (2 minutes 54 seconds), and it revealed that the only reason 
for non-attendance was that the individual’s GP had recently referred them for bowel 
investigations. For the second PN call, the individual stated that they had forgotten their 
appointment and asked to rebook before permission to record was obtained. Of the 
remaining participants, 10 failed to answer all call attempts, 4 had an invalid or wrong 
number, and 3 answered but declined participation (see Figure 1). 
Attendance follow-up (Intention to treat) 
Attendance data was assessed for each consenting individual, 3 months after the last PN 
call attempt was made. In this time, one control participant had self-referred and attended a 
new BSS appointment and three PN participants (one failed to answer PN calls, one 
received a PN call, and one was lost within the study and so the PN intervention was not 
attempted) rebooked and attended a BSS appointment. BSS attendance levels then 
increased to 81.4% (n=35) and 82.6% (n=90) for the control and PN groups respectively.  
End of Study Questionnaires 
110 participants completed ESQs; the majority of these had attended their original BSS 
appointment (n = 104; male = 54) and therefore none had received the PN intervention. 
While comparisons between those who did and did not receive the intervention were not 
possible, useful data emerged regarding the BSS experience: 98.1% were satisfied with their 
choice to attend, 97.2% were satisfied with their test experience, and 100% were satisfied 
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with the support they received throughout the BSS experience. The majority of participants 
reported no or mild pain (59.6%) and indicated no or mild embarrassment (78.9%). 
Furthermore, 30.4% found it less painful and 46.2% less embarrassing than expected. Table 
1 shows the breakdown of these responses. 
Although the majority of attendees were able to correctly answer 10 knowledge questions 
presented regarding BSS, there remained a notable percentage of BSS attendees who 
answered these questions incorrectly or with uncertainty. For example, 23% did not believe  
that BSS can help prevent bowel cancer and 18% did not consider bowel cancer to be a 
common cancer. Of particular interest was that 60% did not know that BSS was a one-off 
test. 
Table 1: End of Study Questionnaires 
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SSP interviews 
All six SSPs were interviewed (range:19 to 41 minutes). Overall, SSPs found the PN training 
to be very useful and were confident in delivering the intervention. However, they also 
expressed some concerns about PN and highlighted possible reasons why it was 
unsuccesful for this patient group. SSPs felt that within South Tyneside, individuals not 
wanting to attend BSS would also not want to discuss their reasons: 
 
Attenders (n = 104) 
Question % (n) 
I am satisfied with my choice to attend BSS  
Strongly agree 67.3 (70) 
Agree 30.8 (32) 
Disagree 1.0 (1) 
Strongly disagree 1.0 (1) 
Overall, how satisfied were you with your test experience?  
Very satisfied 63.5 (66) 
Satisfied 33.7 (35) 
Dissatisfied 1.0 (1) 
Very dissatisfied 1.9 (2) 
Overall, how satisfied were you with the level of support you received throughout the 
BSS experience? 
Very satisfied 88.5 (92) 
Satisfied 11.5 (12) 
Dissatisfied 0.0 (0) 
Very Dissatisfied 0.0 (0) 
How much pain did you feel during your test?  
None  17.3 (18) 
Mild 42.3 (44) 
Moderate 27.9 (29) 
Severe 12.5 (13) 
Was your test more or less painful than you expected?  
More painful 23.5 (24) 
As expected 45.1 (46) 
Less painful 30.4 (31) 
How much embarrassment did you feel during your test  
None  43.3 (45) 
Mild 35.6 (37) 
Moderate 17.3 (18) 
Severe 3.8 (4) 
Was your test more or less embarrassing than you expected?  
More embarrassing 5.8 (6) 
As expected 48.1 (50) 
Less embarrassing 46.2 (48) 
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‘If they’re not going to take part in something then you’re probably not going to consent to be 
contacted after because you’ve already made your mind up that you’re not going to attend’. 
(SSP5) 
Addtionally, they mentioned that people in their area were largely unaware of BSS, and 
some would have been anxious upon receiving the invitation letters as a consequence: 
‘I think because people don't really know what bowel scope screening is. I think some people 
were frightened because they thought that their GPs had referred them in. I think there’s not 
enough information out about bowel scope screening as yet’. (SSP4) 
SSPs also worried that patients would have been overwhelmed by all the information they 
received about both BSS and the study simultaneously, and this may have deterred some 
individuals from participating. This may also have caused confusion about whether patients 
were consenting to take part in screening or a research study, and perhaps some attended 
screening under the assumption that it was part of the study: 
‘I think it was confusing for them. I think they received a lot of information because they were 
receiving the navigation information and they were also receiving information regarding bowel 
screening. I think it was probably too much all at one time for them to comprehend. I think it 
probably put some patients off, and certainly from the experience that I had from consenting 
people for bowel scope screening. One lady that springs to mind was a school teacher; she 
thought that she was consenting for a study rather than for a screening investigation. I think it 
created confusion.’ (SSP4) 
In addition, SSPs expressed difficulty with trying to contact non-responders eligible for PN, 
and commented that many participants had provided false telephone numbers or did not 
answer. Those they were able to contact often hung up or seemed uninterested in talking to 
them. These difficulties in contacting patients meant SSPs needed to repeat phone calls on 
different days and times, which was perceived as a demanding addition to the their 
workload: 
‘I've been ringing the patients on different days, different times of the day, that sort of thing, 
to try and… if people are at work and things, to try and catch them when they're there. So, 
doing it on top [of] my everyday other clinical commitments, it has actually been quite a 
demand.’ (SSP3) 
Cost Analysis 
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The mean costs per participatant of PN and usual care were £18.92 and £12.10, 
respectively. The difference in costs (£6.72 per participant) was driven mainly by the cost of 
SSP time associated with trying to contact non-responders. 
 
Discussion 
This study explored the feasibility of SSPs offering PN to patients at South Tyneside 
Screening Centre who did not confirm or attend their appointment, in order to engage/re-
engage them with the opportunity to have BSS. The introduction of PN, with this patient 
group, was not found to be feasible within the current programme structure.   
This was the first study to apply PN to BSS in an area of low uptake in the UK. A range of 
quantitative and qualitative data was gathered to assess the feasibility of the intervention, 
including BSS attendance, reasons for study non-participation, informed choice about BSS, 
an SSP evaluation and a cost evaluation. The study provides important practical 
implications, because it suggests that SSP led PN is currently not a feasible method for 
increasing screening uptake, in areas where BSS is low, predominantly due to restricted 
access to contact details. A cost analysis also suggested that compared with other 
interventions aimed at increasing BSS uptake, PN was slightly more expensive to deliver, 
though the cost implications were modest and we cannot give a fair evaluation of the money 
saved through the prevention of CRC had the PN process not been restricted. 
The main challenge of this study was the recruitment of prospective BSS invitees which led 
to a biased, self-selected sample of highly motivated participants. SSPs suggested that a 
main problem lay with sending study invitations alongside the BSS pre-invitations. While this 
was the only option in the context of a SSP-led study, it appeared to cause confusion among 
some patients, with an example given by one SSP of a woman assuming she was taking 
part in the study when she was attending her BSS appointment. Indeed, this aspect of the 
study design, while included to allow ease of access to appropriate patients, to avoid an 
additional mail out, and to keep it separate from receipt of the BSS appointment letter, may 
still have led to information overload, negatively affecting participation rates. 
This design element also related to the main obstacle for PN in the screening context, 
namely the lack of availability of patient telephone numbers by the screening programme. As 
a result, we had to ask participants to provide their telephone number during the study 
consent process. This meant there was a selection bias, because we were only able to 
contact individuals who were engaged with BSS and willing to take part in research, rather 
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than those who were unengaged and arguably most in need of navigation (e.g. those who 
did not read the invitation letters). SSPs commented that they felt that those who did not 
want to take part in BSS, may have also not wanted to discuss BSS and their reasons for 
non-attendance with them over the phone. It was, therefore, not surprising that the uptake 
was much higher in our sample (79% and 80% in the control and intervention groups 
respectively) compared with uptake observed within South Tyneside generally (37%) and 
specifically within South Tyneside District Hospital (35%) during the study period.[2][personal 
communication; Ritchie, 2016).   
SSPs also faced great difficulty establishing contact with participants who had consented to 
the study, with many unanswered calls and false telephone numbers provided. It was not 
possible to verify telephone numbers ahead of the PN intervention and we were not able to 
assess and compare the proportion of incorrect telephone numbers in the control group. 
While one SSP considered this a “mischievous side” of the population, we perhaps could 
have benefited from asking consenting participants to provide an indication of the best day 
and time to contact them by phone. Additionally, as per usual practice within the centre, 
navigators did not leave voicemail messages, but this may have helped alert patients to a 
subsequent call and perhaps offered reassurance of the friendly voice they were likely to 
receive following their non-response or non-attendance. A request to be recorded upon 
answering the call may also have put people off continuing the conversation and refusing 
PN. 
Future research would benefit from finding ways to contact patients without first having them 
provide their number and consent to being called. For example, by providing the navigation 
service through primary care (using health care assistants, nurses or volunteers trained in 
BSS navigation), the telephone numbers of patients will already be available and a call from 
their General Practice may be considered a more familiar and acceptable approach. 
However, in a study involving telephone communication through a General Practice in a 
socioeconomically deprived area in London to increase FOBt uptake specifically, similar 
difficulties ensued; 46% of patients to be contacted had an incorrect number, or no number 
at all documented.[9] Exploration of using other communication avenues to personally 
promote healthcare initiatives and opportunities to unengaged audiences is required. 
The observation from SSP interviews that BSS awareness is low in South Tyneside 
suggests that an intervention to raise awareness might initially be more useful than PN in 
increasing BSS uptake in future. It is possible that PN is better-suited to patients who are 
already aware of an available opportunity or concept. Alternatively, a decision aid could 
perhaps be used in future, alongside or ahead of PN, to help increase patients’ knowledge of 
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BSS, including its risks and benefits, and encourage consideration. A recent American study 
found that providing patients with a decision aid, as well as PN, led to greatly increased 
bowel cancer screening uptake within six months when compared with usual care (68% 
versus 27%).[17] 
To conclude, PN provided by SSPs was not found to be a feasible intervention to increase 
BSS among patients in South Tyneside Screening Centre. This was likely due to the lack of 
access to patient telephone numbers, causing a selection bias whereby mostly patients 
engaged with BSS participated in the research, and thus those most in need of navigation 
were uncontactable. In addition to this there were difficulties contacting patients who had 
consented to the study, including unanswered calls and false telephone numbers. 
Subsequently, the feasibility of PN as an intervention in itself could not be assessed with this 
population. While the delivery of PN was not possible in the present study, alternatives to 
allow an evaluation of the impact of a personalised navigation approach to help patients in 
England engage with bowel screening opportunities is sought.  
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Figure legends 
Figure 1: Flow diagram of study participation 
